Intracoronary Abciximab Improves Outcomes in Diabetic Patients Undergoing Primary PCI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention
J Am Coll Cardiol 2016 Aug 16;68(7)727-738, R Piccolo, I Eitel, G Galasso, A Dominguez-Rodriguez, AZ Iversen, P Abreu-Gonzalez, S Windecker, H Thiele, F PiscioneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.